Description

PT-141

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide derived from the melanocortin peptide family. It functions as a melanocortin receptor agonist and has been studied for its activity within central nervous system signalling pathways, particularly those associated with sexual desire, arousal, neuroendocrine regulation, and reproductive physiology.

Current scientific research includes in vitro, preclinical, and clinical investigations into melanocortin receptor signalling and the neurological mechanisms involved in sexual response. The precise pathway through which bremelanotide produces its clinical effects is not fully established.

Manufactured to high analytical standards, this compound is supplied as lyophilised powder for laboratory research and analytical applications.

Purity: ≥99% (HPLC)
Form: Lyophilised Powder
Quantity: 10mg
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1025.2 g/mol, free base
CAS: 189691-06-3
Research: PubMed

Handling and Storage: Store sealed in a cool, dry environment away from direct light and moisture. For extended storage, keep refrigerated at 2°C to 8°C unless different conditions are specified on the lot-specific Certificate of Analysis. Avoid repeated temperature cycling and exposure to moisture.

Regulatory Notice: Laboratory Research Use Only. This product is supplied strictly for in vitro laboratory research, analytical, or educational purposes. It is not intended for human or veterinary use, consumption, compounding, therapeutic administration, or diagnostic purposes. This 10mg research product is not the FDA-approved bremelanotide prescription product.

Certificates of Analysis and HPLC test results, including internal and ISO 17025-accredited third-party documentation where applicable, are available upon request to qualified researchers and clinicians, subject to credential verification. Please include institutional affiliation and intended research use with your request.